Company / Interest Expense
MANNKIND CORP Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$15.2M
FY2023
5-year range
$15.0M / $15.2M
FY2019-FY2023
Trend
+0.9%
vs FY2022
Sector context
#21 of 42
Health Care
What the data says
At $15M, MANNKIND CORP's interest expense ranks #22 of 42 in the Health Care sector. Interest Expense has fluctuated over the past 8 years, ranging from $5M in FY2018 to $16M in FY2016.
Based on SEC 10-K filings.
$15M in FY2023 with a 5-year CAGR of +24.3%.
Remained stable around $15M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +17.0%
- 5-Year CAGR
- +24.3%
- 10-Year CAGR
- -
Sector benchmark
#22 of 42 in Health CareTop 50% of 42This company $15.2M Sector average $305.3M
▼
-95.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +24.3%, indicating consistent growth.
- In FY2023, interest expense increased 0.9% year-over-year.
- Ranks #21 out of 42 companies in the Health Care sector.
- Peak interest expense was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.74 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $15.2M | +0.9% |
| FY2022 | $15.0M | -1.3% |
| FY2021 | $15.2M | +60.5% |
| FY2020 | $9.5M | +50.2% |
| FY2019 | $6.3M | +23.2% |
| FY2018 | $5.1M | -46.1% |
| FY2017 | $9.5M | -39.0% |
| FY2016 | $15.6M | -35.4% |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026